ライフサイエンスコーパス: ferricyanide

1 xidized by either hydrogen peroxide, air, or ferricyanide.

2 +) form by treatment with a 3-fold excess of ferricyanide.

3 nown electron acceptors, benzyl viologen and ferricyanide.

4 cyte lysates treated with an oxidant such as ferricyanide.

5 et state of rose bengal and its quenching by ferricyanide.

6 ytochrome by semidehydroascorbate but not by ferricyanide.

7 electrode (1-mm diameter) in the presence of ferricyanide.

8 but was inhibited at high concentrations of ferricyanide.

9 found to refold partially on oxidation with ferricyanide.

10 th for the reduction of biotin sulfoxide and ferricyanide.

11 -isoprostane formation due to extravesicular ferricyanide.

12 tochrome c, 2,6-dichlorophenolindophenol, or ferricyanide.

13 f intravesicular ascorbate by extravesicular ferricyanide.

14 f-the-art aqueous TREC electrolyte potassium ferricyanide.

15 ion containing the redox marker ferrocyanide/ferricyanide.

16 ive coupling species in situ using potassium ferricyanide.

17 and increase in peak splitting for potassium ferricyanide.

18 rons from intracellular Asc to extracellular ferricyanide.

19 antioxidant properties of vitamin C against ferricyanide.

20 2p to carry the NADPH-dependent reduction of ferricyanide.

21 the paramagnetic broadening agent potassium ferricyanide.

22 osed to a trans-membrane oxidant stress from ferricyanide.

23 les-hydrogen sulfide, thioacetate(12,14) and ferricyanide(12,14-17) or cyanoacetylene(8,14)-to yield

24 uction of the artificial electron acceptors: ferricyanide, 2,6-dichloroindophenol, 3-acetylpyridine a

25 Ferricyanide, 2,6-dichlorophenolindophenol, several quin

26 nd partially inhibited by myxothiazol (58%), ferricyanide (28%), and dithiothreitol (81%).

27 , largely superoxide dismutase-independent), ferricyanide (470 min(-1)), and other electron acceptors

28 Co-administration of AS with ferricyanide, a one-electron oxidant that converts NO(-)

29 Addition of ferricyanide, a strong oxidant, to the oxidized complex

30 ide reduction kinetic analysis (variation of ferricyanide absorption with time), much more sensitive

31 NADH:ferricyanide activity was 219 +/- 9.7 mumol/min/mg by us

32 al complex did not impair decyl-plastoquinol-ferricyanide activity.

33 the kinetics of NO release before and after ferricyanide addition in tissue homogenates to mathemati

34 T, test cells were treated with drugs before ferricyanide addition; cell counts from the amperometric

35 , the mass-transport controlled reduction of ferricyanide, allows for a proof of principle evaluation

36 Ferricyanide also generated dehydroascorbic acid that ac

37 uring purification and to use both potassium ferricyanide and 2,6-dichloroindophenol as electron acce

38 dditionally, two unpoised systems (potassium ferricyanide and ascorbic acid) were studied to evaluate

39 Dual wavelength analysis at 405 (ferricyanide and biomass) and 550 nm (biomass), allowed

40 and flow modes were evaluated using aqueous ferricyanide and compare favorably to those reported pre

41 from MoR, has similar kinetic properties for ferricyanide and cytochrome c reductase activities and v

42 sures of flavin and heme reduction kinetics, ferricyanide and cytochrome c reduction, and NO synthesi

43 +/CaM, as measured by reduction of potassium ferricyanide and cytochrome c.

44 resuspension, incubation in the presence of ferricyanide and finally ferrocyanide amperometry in dru

45 nd-order rate constants for the reactions of ferricyanide and oxygen.

46 We have found that ferricyanide and pentacyanoaminoferrate can be used as e

47 ity of the electrodes using the test analyte ferricyanide and perform recordings of quantal exocytosi

48 A combination of the electron acceptor, ferricyanide and the DeltapH indicator, 9-aminoacridine,

49 phenol-indophenol, 2) the iron (III) complex ferricyanide, and 3) the keto-acids oxaloacetate and pyr

50 side was inhibited by nitroblue tetrazolium, ferricyanide, and diphenyliodonium.

51 ed by the presence of nitroblue tetrazolium, ferricyanide, and diphenyliodonium.

52 in that reduces cytochrome c, methemoglobin, ferricyanide, and molecular oxygen in vitro.

53 he pH response while quinhydrone, ferro- and ferricyanide, and sodium sulfide have marked effects.

54 oactive potassium ferrocyanide and potassium ferricyanide, and supporting electrolyte, potassium chlo

55 and Lys-146 were much more accessible to the ferricyanide anion in the apoE3.DMPC complex than in the

56 of the substrates cytochrome c and potassium ferricyanide approximately 100-fold, while substitution

57 ting various target analytes using potassium ferricyanide as a redox probe, its unsuitability for blo

58 trochemical impedance change using potassium ferricyanide as a redox probe.

59 y characterized with a food dye solution and ferricyanide as a redox probe.

60 The purified enzyme also utilized ferricyanide as an artificial electron acceptor, which e

61 s typically been studied using extracellular ferricyanide as an electron acceptor.

62 metric analysis was performed with potassium ferricyanide as an electron mediator under argon or atmo

63 Using potassium ferricyanide as an oxidant, assemblies containing o-amin

64 The A129T MSR mutant transfers electrons to ferricyanide as efficiently as wild type MSR but the rat

65 cal detection in the presence of 10 mM ferro/ferricyanide as redox probe, the sensor exhibited a very

66 l pulse voltammetries using the ferrocyanide/ferricyanide as redox probe.

67 t SOR or SOO activities with ferrocyanide or ferricyanide as the redox partners.

68 re one-electron redox couples such as ferro-/ferricyanide as well as improved electron transfer kinet

69 The enzyme exhibited Nr activity via ferricyanide assay.

70 ction tests and CV measurements of potassium ferricyanide at a 1 V/s scanning rate.

71 is-light electron generating system, reduces ferricyanide at a rate of 1.8 mumol/min/ nmol reductase.

72 inone was unusually insensitive to oxygen or ferricyanide at pH 8 and showed absorbance peaks at 372

73 ase domain of CYPOR reduced cytochrome c and ferricyanide at rates 2-fold higher than that of native

74 N-bound reductase catalyzes the reduction of ferricyanide at rates of 0.43 and 0.28 mumol/min/ nmol r

75 A ferricyanide-based electrochemical cell respiration assa

76 tive chemiluminescence in conjunction with a ferricyanide-based hemoglobin oxidation assay to prevent

77 Indeed, a ferricyanide-based spectrophotometric assay revealed tha

78 cts were blocked by myoglobin oxidation with ferricyanide but not by the xanthine oxidoreductase inhi

79 ocyanide by O(2) as well as the reduction of ferricyanide by O(2).

80 from PW to PB is facilitated by a potassium ferricyanide-catalyzed oxidation of leucomethylene blue

81 Oxidation of the (abcd)4 complex with ferricyanide causes complete dissociation of chain d fro

82 tdialysis and after oxidation with potassium ferricyanide, combined with the absence of a Soret peak

83 ctron from an Fe atom in solvated ferro- and ferricyanide complexes.

84 icted by the Beer-Lambert law for a range of ferricyanide concentrations from 0.005 to 0.3 mM and sho

85 from Ludox, ferrocenemethanol and potassium ferricyanide diffused at rates identical to that measure

86 ghosts with the membrane-impermeant oxidant ferricyanide doubled the ghost membrane concentration of

87 ed to quantitatively detect the reduction of ferricyanide down to a concentration of approximately 10

88 Oxidant (ferricyanide) electrochemically dosed at small rates (<o

89 Ferricyanide electrochemistry is totally inhibited on gr

90 a recently described modified assay using a ferricyanide-enhanced reaction mix at biologically relev

91 ified that redox cycling of the ferrocyanide/ferricyanide (Fe(CN)(6) (3-/4-)) couple occurs both in t

92 CN)6]K4, ferric tacn [Fe(III)(tacn)2]Br3 and ferricyanide [Fe(III)(CN)6]K3.

93 the proof-of-concept experiments described, ferricyanide, Fe(CN)6(3-), was produced by the transport

94 sed one-electron transfer systems (potassium ferricyanide/ferrocyanide and ferrous/ferric ammonium su

95 ugh a series of targeted experiments using a ferricyanide/ferrocyanide redox pair to validate electro

96 dopamine, hexaammineruthenium(III) chloride, ferricyanide/ferrocyanide, uric acid, and ascorbic acid.

97 d n-type GaP particles with iodide, sulfite, ferricyanide, ferrous ion, and hydrosulfide as sacrifici

98 e anodic inlet and another drop of potassium ferricyanide for cathodic reaction flowed through patter

99 of contrast with osmium tetroxide/potassium ferricyanide, for BSE imaging, for the preparation and p

100 sulfite followed by partial reoxidation with ferricyanide generates an EPR spectrum with g-values sim

101 edox couple potassium ferrocyanide/potassium ferricyanide (HCF).

102 blood when MetHb formers, such as potassium ferricyanide, hydroxylamine, sodium nitrite, and 4-dimet

103 ial recovery of enzyme activity by potassium ferricyanide illuminated an alternative irreversible mec

104 ion, for various concentrations of potassium ferricyanide in potassium nitrate electrolyte at various

105 tic activity do not support the reduction of ferricyanide in the Tris-light system in the absence of

106 on acceptors (molecular oxygen, APAD(+), and ferricyanide), in the presence and absence of a competit

107 h potential oxidant, such as cytochrome c or ferricyanide, in the presence of phospholipid vesicles o

108 Oxidation of the C199HT enzyme with ferricyanide increases the amount of the 3Fe cluster by

109 ate resealed within ghosts protected against ferricyanide-induced oxidation of endogenous alpha-tocop

110 mmol/L nitroblue tetrazolium and 0.1 mmol/L ferricyanide) inhibited pulmonary artery relaxation to n

111 us selectivity and sensitivity of the nickel ferricyanide interface is proposed.

112 ricyanide to the assay buffer; the effect of ferricyanide is attributed to oxidation of H2O2-dismutat

113 Potassium ferricyanide is known to oxidize ferrous sGC to the ferr

114 tro-oxidation of ferrocyanide, produced when ferricyanide is reduced by bacterial electron-transport.

115 A double mediator system is used in which ferricyanide is the final electron acceptor (the reporte

116 F-kappaB activation by hydrogen peroxide and ferricyanide, it had no effect of tumor necrosis factor-

117 Oxidation of RumA by ferricyanide leads to loss of the 390-nm band and appear

118 Reoxidation to Mo(V) by ferricyanide leaves bound sulfate trapped at the active

119 proach is characterized by imaging potassium ferricyanide microparticles and applied to detect lipid

120 d biomass) and 550 nm (biomass), allowed for ferricyanide monitoring without interference of biomass

121 ucing power activity assessed with potassium ferricyanide of sheep whey protein was 1.3mg/ml.

122 ical signals from a soluble redox indicator, ferricyanide, on nitrocellulose films treated by cellula

123 f the nNOS heme or cytochrome c, but not for ferricyanide or dichlorophenolindolphenol, and establish

124 n acceptors, methyl viologen (MV), potassium ferricyanide, or dichloroindophenol.

125 sitive to oxygen, and ferric sGC prepared by ferricyanide oxidation has a 5c high-spin heme complex.

126 Ferricyanide oxidation of anaerobically reconstituted c-

127 Ferricyanide oxidation of the C415A mutant yielded a spe

128 ster using conventional methods of oxygen or ferricyanide oxidation or thiol exchange were not succes

129 By analogy with the properties of the ferricyanide-oxidized [4Fe-4S] cluster in Azotobacter vi

130 EPR spectra of ferricyanide-oxidized RumA show a fraction (<8%) of the

131 is estimated from a dithionite-reduced-minus-ferricyanide-oxidized spectrum.

132 Beyond illuminating the elusive ferricyanide photochemistry, these results show how curr

133 troscopy and scattering study of the aqueous ferricyanide photochemistry, utilizing the combined Fe K

134 The electrochemistry of a ferro/ferricyanide probe was used to characterise the TnT MIP

135 The reduction current of ferricyanide, product of the enzymatic reaction, is meas

136 eptors such as 2,6-dichlorophenolindophenol, ferricyanide, quinones, and molecular oxygen (O(2)).

137 rea of electrodes becoming accessible to the ferricyanide reaction after nitrocellulose digestion by

138 g a change in the reaction kinetics of ferro-ferricyanide redox couple at the electrode upon hybridiz

139 (SWV) reduction peak signal of ferrocyanide/ferricyanide redox couple due to the removal of the nega

140 l change alters the access of a ferrocyanide/ferricyanide redox couple to the aptasensor surface.

141 ts carried out on the potassium ferrocyanide/ferricyanide redox couple.

142 ocess; in this case the classic ferrocyanide/ferricyanide redox couple.

143 increase in reaction impedance for the ferro-ferricyanide redox couple.

144 ation resulted in a suppression of the ferro/ferricyanide redox current.

145 ation resulted in a suppression of the ferro/ferricyanide redox process.

146 posome-treated cells completely restored the ferricyanide-reducing capacity of the ghosts.

147 he effects of viscosogen on cytochrome c and ferricyanide reductase activities of holo-NaR and ferric

148 xhibited a low level of the cytochrome c and ferricyanide reductase activities, which either did not

149 had slower NADPH-dependent cytochrome c and ferricyanide reductase activities, which were associated

150 All four mutants showed decreased NADH:ferricyanide reductase activities, with kcat decreasing

151 A high ferricyanide reductase activity (indicative of NADH:cyto

152 ed antibody immunoprecipitated both the NADH-ferricyanide reductase activity and NADH-coenzyme Q(0) r

153 The FAD domain retains a high level of ferricyanide reductase activity but no cytochrome c redu

154 Whereas an NADH:ferricyanide reductase activity is evident in open membr

155 cyanide reductase activities of holo-NaR and ferricyanide reductase activity of the recombinant molyb

156 Ferricyanide reductase activity was unaffected, indicati

157 thracycline antitumor agents and a candidate ferricyanide reductase for plasma membrane electron tran

158 ly lower (<or=1000x) cytochrome c reductase, ferricyanide reductase, and NADPH oxidase activities tha

159 uctase activity but not the activity of NADH-ferricyanide reductase.

160 NH2-FAD, and riboflavin, are able to support ferricyanide reduction at a rate of 0.40, 0.52, 0.87, an

161 -reconstituted FMN-bound reductase catalyzes ferricyanide reduction at a rate of 1.1 mumol/min/nmol r

162 reductase in this system is able to catalyze ferricyanide reduction at a rate of 1.6 mumol/ min/nmol

163 1412D nNOS catalyzed faster cytochrome c and ferricyanide reduction but displayed slower steady-state

164 NADPH oxidation, cytochrome c reduction, and ferricyanide reduction by full-length eNOS or its isolat

165 Ferricyanide reduction kinetic analysis (variation of fe

166 sed on dual wavelength analysis of bacterial ferricyanide reduction kinetics is presented, using Esch

167 mbrane during the resealing step, subsequent ferricyanide reduction was enhanced.

168 Ferricyanide reduction was unaffected by cav-1P in all c

169 s measured indirectly as ascorbate-dependent ferricyanide reduction, correlated with the content of a

170 influence eNOS oxygenase domain function or ferricyanide reduction, it does potentiate the ability o

171 membrane content of alpha-tocopherol and in ferricyanide reduction.

172 ive titrations with dithionite and potassium ferricyanide, respectively, show that FAD is the only re

173 Reoxidation of the ferrous enzyme with ferricyanide results in alleviation of inhibition.

174 esponse of redox active molecules (potassium ferricyanide, ruthenium(III) hexammine, and ferrocene me

175 rt a model liposome system in which internal ferricyanide serves as an oxidant and external ascorbate

176 um or heparinized blood containing potassium ferricyanide showed ideal voltammetry while significant

177 Shift reagent experiments with potassium ferricyanide showed that Lys-143 and Lys-146 were much m

178 The color is not restored by ferricyanide, showing that the protein is modified irrev

179 molecular recognition element, and the ferro/ferricyanide solution as a redox probe, was developed.

180 was evaluated by measuring the absorbance of ferricyanide solutions at 420 nm.

181 een demonstrated via measurements on aqueous ferricyanide solutions using sample volumes as low as 20

182 t quality was achieved in static and flowing ferricyanide solutions, respectively.

183 sarcoplasmic reticulum (visualized by osmium ferricyanide staining of thin tissue sections), which su

184 Ferricyanide-stimulated ascorbate recycling from dehydro

185 H, Q-1, and the artificial electron acceptor ferricyanide strongly support an electron transport path

186 s the pi-back-bonding features in ferro- and ferricyanide that are significantly more intense in L-ed

187 After oxidation of the haem with ferricyanide, the absorbance spectrum of the reduced cyt

188 pair, and with the weak one-electron oxidant ferricyanide, the OG nucleoside reactivity is >6000-fold

189 Ferricyanide titration showed that the C415A mutant cont

190 ials down to -650 mV, but can be oxidized by ferricyanide to an S = 1/2 [4Fe-4S]3+ state (g = 2.09, 2

191 ic redox buffer composed of ferrocyanide and ferricyanide to control the potential between the hydrog

192 ar spin I = 3/2), followed by reoxidation by ferricyanide to generate the Mo(V) state of the active c

193 but was completely suppressed by adding 5 mM ferricyanide to the assay buffer; the effect of ferricya

194 Ferricyanide, tris(2,2'-bipyridine) ruthenium(II) chlori

195 The protein is fully capable of reducing ferricyanide, using NADPH as the electron donor.

196 Ferricyanide voltammetric responses correlate with the i

197 The Michaelis constant (K(M)) value for ferricyanide was 0.86 mM.

198 Using a small-molecule-based screen, ferricyanide was identified as a mild and efficient oxid

199 ochrome c, 2,6-dichlorophenolindophenol, and ferricyanide was inhibited by the addition of any of the

200 and nearly wild-type activity at pH 7.0 when ferricyanide was the electron acceptor.

201 Ferricyanide was used as an alternative electron accepto

202 Ferricyanide was used both to induce oxidant stress acro

203 rometry whereas the product of the reaction (ferricyanide) was recorded by absorbance.

204 Using the electron acceptor ferricyanide, we found that recombinant p67PHOX from bac

205 constant-potential electrolysis of potassium ferricyanide were used to characterize this rotating sam

206 releases NO at neutral pH in the presence of ferricyanide when reacted with an Fe(III) ligand like az

207 ponses at cathodic peak (+0.2V) of potassium ferricyanide, whereas pyruvate concentration was determi

208 cal impedance spectroscopy with ferrocyanide/ferricyanide, which revealed a very low charge-transfer

209 The FLDR reduces potassium ferricyanide with a kcat of 1610.3 min(-1) and a Km of 2

210 Erythrocytes reduced ferricyanide with generation of intracellular ascorbate

211 ata of cyclic voltammetry with 1mM potassium ferricyanide) with respect to conventional electrodes te

212 The presence of electrogenerated ferricyanide within the resulting evanescent field, beyo